North America Warts Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Common Warts, Genital Warts, Flat Warts, and Others); Treatment (Physical Destruction, Immunomodulation, and Chemical Destruction); End User (Hospitals, Homecare, Specialty Clinics, and Others)
Market Introduction
Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.
Thus, the new product developments are expected to create a significant demand for warts therapeutics in the coming years, which is further anticipated to drive the warts therapeutics market.
The demand warts treatment is reduced due to Covid 19 as the focus of healthcare in overall world is on save lives in Covid 19 pandemic. The Covid 19, which is continuing to worsen around the world, is causing massive disruptions in global supply chains, consumer markets and the economy as a whole. As a result of the measures implemented by governments around the world. There is a risk of a temporary and significant decline in demand for dermatology treatment services Worldwide. For instance, in March 2020, regulations from the Centers for Medicare & Medicaid Services suggested that implementation of tele dermatology platforms in academic dermatology departments and changes to the iPledge system for isotretinoin prescribing that align well with telemedicine and the possibility of furthering the outreach of dermatologic care. However, as the vaccination drive progresses over the period of time the markets will come to normal situation which is expected to offer several opportunities for wart treatment market in North America region.
Get more information on this report :
Market Overview and Dynamics
The Warts therapeutics market in North America is expected to grow from US$ 681.3 million in 2021 to US$ 869.8 million by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028. As per the WHO, over 1 million people acquire STIs every day. Early interventions could reduce the incidence of STIs. The stages of intervention include primary prevention (information, education, and communication campaigns), secondary prevention (screening and treatment of precancerous lesions), tertiary prevention (diagnosis and treatment of invasive cervical cancer), and palliative care. Many governments have adopted various strategies to enhance awareness regarding STIs and their associated complications. For instance, IKnowUShould2 campaign was started in 2012 with an objective to improve knowledge and testing behaviors for STIs among adolescents; it targeted youth in Philadelphia, belonging to the age group 13–24. The campaign uses traditional media (print advertisements, radio, etc.) and social media (websites, Facebook, Twitter, Instagram, and YouTube) to raise awareness about STIs and associated risk factors. Thus, increasing awareness regarding STIs offers lucrative opportunities for the future growth of the warts therapeutics market players.
Key Market Segments
In terms of type, the common warts segment accounted for the largest share of the North America warts therapeutics market in 2020. In terms of treatment, the physical destruction segment accounted for the largest share of the North America warts therapeutics market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the North America warts therapeutics market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the warts therapeutics market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Bausch Health Companies Inc., Nielsen BioSciences, Inc., Euro Vital Pharma GmbH, Cipla Inc., Koninklijke Utermöhlen NV, Novan, Inc., Scholl's Wellness Company, Teva Pharmaceutical Industries Ltd, and Verrica Pharmaceuticals Inc., GlaxoSmithKline plc., and AIM ImmunoTech Inc.
Reasons to buy report
- To understand the North America Warts therapeutics market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America Warts therapeutics market
- Efficiently plan M&A and partnership deals in North America Warts therapeutics market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America Warts therapeutics market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
NORTH AMERICA WARTS THERAPEUTICS MARKET SEGMENTATION
By Type
- Common Warts
- Genital Warts
- Flat Warts
- Others
By Treatment
- Physical Destruction
- Cryotherapy
- Surgical Removal
- Laser Treatment
- Immunomodulation
- Interferons
- Retinoids
- Zinc
- Chemical Destruction
- Bleomycin
- Cantharidin
- Salicylic Acid
- Others
By End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Country
- North America
- US
- Canada
- Mexico
Companies Mentioned
- Bausch Health Companies Inc.
- Nielsen BioSciences, Inc.
- Euro Vital Pharma GmbH
- Cipla Inc.
- Koninklijke Utermöhlen NV
- Novan, Inc.
- Scholl's Wellness Company
- Teva Pharmaceutical Industries Ltd
- Verrica Pharmaceuticals Inc.
- GlaxoSmithKline plc.
- AIM ImmunoTech Inc
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Warts Therapeutics Market – By Type
1.3.2 Warts Therapeutics Market – By Treatment
1.3.3 Warts Therapeutics Market – By End User
1.3.4 North America Warts Therapeutics Market – By Country
2. North America Warts Therapeutics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Warts Therapeutics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Warts Therapeutics Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Warts Therapeutics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Human Papillomavirus Infections and Recurrence of Genital Warts
5.1.2 New Product Developments
5.2 Market Restraints
5.2.1 Poor Diagnostics Scenario in Low-Income Countries
5.3 Market Opportunities
5.3.1 Increasing Awareness Regarding STIs
5.4 Future Trends
5.4.1 Emergence of New Technologies
5.5 Impact Analysis
6. Warts Therapeutics Market – North America Analysis
6.1 North America Warts Therapeutics Market Revenue Forecasts and Analysis
7. North America Warts Therapeutics Market Analysis and Forecasts To 2028 – By Type
7.1 Overview
7.2 Warts Therapeutics Market Revenue Share, by Type (2020 and 2028)
7.3 Common Warts
7.3.1 Overview
7.3.2 Common Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Genital Warts
7.4.1 Overview
7.4.2 Genital Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Flat Warts
7.5.1 Overview
7.5.2 Flat Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Warts Therapeutics Market Analysis and Forecasts To 2028 – By Treatment
8.1 Overview
8.2 Warts Therapeutics Market Revenue Share, by Treatment (2020 and 2028)
8.3 Physical Destruction
8.3.1 Overview
8.3.2 Physical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Cryotherapy
8.3.2.2 Cryotherapy: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Surgical Removal
8.3.2.4 Surgical Removal: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.5 Laser Treatment
8.3.2.6 Laser Treatment: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Immunomodulation
8.4.1 Overview
8.4.2 Immunomodulation: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4.2.1 Interferons
8.4.2.2 Interferons: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4.2.3 Retinoids
8.4.2.4 Retinoids: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4.2.5 Zinc
8.4.2.6 Zinc: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Chemical Destruction
8.5.1 Overview
8.5.2 Chemical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.2.1 Bleomycin
8.5.2.2 Bleomycin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.3 Cantharidin
8.5.3.1 Overview
8.5.3.2 Cantharidin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.3.3 Salicylic Acid
8.5.3.4 Salicylic Acid: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.3.5 Others
8.5.3.6 Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
9. Warts Therapeutics Market Analysis – By End user
9.1 Overview
9.2 Warts Therapeutics Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Warts Hospitals Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Homecare
9.4.1 Overview
9.4.2 Homecare: Warts Homecare Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Specialty Clinics
9.5.1 Overview
9.5.2 Specialty Clinics: Warts Specialty Clinics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
10. Warts Therapeutics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 North America: Warts Therapeutics Market
10.1.1 Overview
10.1.2 North America: Wart Therapeutics Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.1 US Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.2 US Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.3 US Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 US Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Canada: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3.1 Canada Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3.2 Canada Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3.3 Canada Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 Canada Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Mexico: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.1 Mexico Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.2 Mexico Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.3 Mexico Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Mexico Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on North America Warts Therapeutics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 Bausch Health Companies Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Nielsen BioSciences, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Euro Vital Pharma GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Cipla Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Koninklijke Utermöhlen NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Novan, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Scholl's Wellness Company
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Verrica Pharmaceuticals Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 GlaxoSmithKline plc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 AIM ImmunoTech, Inc.
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. US Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 3. US Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 4. US Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 5. US Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. US Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms, Warts Therapeutics Market
LIST OF FIGURES
Figure 1. Warts Therapeutics Market Segmentation
Figure 2. North America Warts Therapeutics Market Overview
Figure 3. Common Warts Segment Held Largest Share Of Type In Warts Therapeutics Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Warts Therapeutics Market - North America PEST Analysis
Figure 6. Warts Therapeutics Market Impact Analysis of Driver and Restraints
Figure 7. North America Warts Therapeutics Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Warts Therapeutics Market Revenue Share, by Type (2020 and 2028)
Figure 9. Common Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Genital Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Flat Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Warts Therapeutics Market Revenue Share, by Treatment (2020 and 2028)
Figure 14. Physical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Cryotherapy: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Surgical Removal: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Laser Treatment: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Immunomodulation: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Interferons: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Retinoids: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Zinc: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Chemical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Bleomycin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cantharidin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Salicylic Acid: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Warts Therapeutics Market Revenue Share, by End User (2020 and 2028)
Figure 28. Hospitals: Warts Hospitals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Homecare: Warts Homecare Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Specialty Clinics: Warts Specialty Clinics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America: Warts Therapeutics Market, by Key Country – Revenue (2021) (USD Million)
Figure 33. North America: Wart Therapeutics Market, by Country, 2021 & 2028 (%)
Figure 34. US Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Canada Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Mexico Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in North American Country Markets
Figure 38. Growth Strategies Done by the Companies in the Market, (%)
- Bausch Health Companies Inc.
- Nielsen BioSciences, Inc.
- Euro Vital Pharma GmbH
- Cipla Inc.
- Koninklijke Utermöhlen NV
- Novan, Inc.
- Scholl's Wellness Company
- Teva Pharmaceutical Industries Ltd
- Verrica Pharmaceuticals Inc.
- GlaxoSmithKline plc.
- AIM ImmunoTech Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America warts therapeutics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America warts therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the warts therapeutics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution